|
Pathways in cancer (K)
|
327
|
7
|
0.0004
|
1.40E-02
|
E2F1,PTEN,AKT2,MSH6,HSP90AA1,JUN,VEGFA
|
|
Direct p53 effectors (N)
|
133
|
5
|
0.0002
|
1.40E-02
|
E2F1,PTEN,SP1,JUN,SMARCA4
|
|
Hepatitis B (K)
|
146
|
5
|
0.0004
|
1.38E-02
|
E2F1,PTEN,AKT2,JUN,YWHAQ
|
|
Nonsense-mediated decay (R)
|
106
|
5
|
0.0001
|
1.55E-02
|
RPL30,UPF1,SMG7,RNPS1,RPL18A
|
|
RNA transport (K)
|
164
|
5
|
0.0006
|
1.50E-02
|
EEF1A1,UPF1,RNPS1,EIF4G2,NUP205
|
|
E2F transcription factor network (N)
|
68
|
4
|
0.0002
|
1.44E-02
|
E2F1,KAT2B,SP1,RRM2
|
|
Estrogen signaling pathway (K)
|
100
|
4
|
0.0009
|
1.69E-02
|
AKT2,HSP90AA1,SP1,JUN
|
|
Glucocorticoid receptor regulatory network (N)
|
77
|
4
|
0.0003
|
1.34E-02
|
SMARCD1,HSP90AA1,JUN,SMARCA4
|
|
HIF-1-alpha transcription factor network (N)
|
66
|
4
|
0.0002
|
2.03E-02
|
NPM1,SP1,JUN,VEGFA
|
|
Huntington disease (P)
|
121
|
4
|
0.0017
|
2.79E-02
|
GAPDH,AKT2,AP2A2,JUN
|
|
Processing of capped intron-containing pre-mRNA (R)
|
138
|
4
|
0.0028
|
3.33E-02
|
DDX23,PCBP1,RNPS1,NUP205
|
|
Prostate cancer (K)
|
89
|
4
|
0.0006
|
1.56E-02
|
E2F1,PTEN,AKT2,HSP90AA1
|
|
Regulation of androgen receptor activity (N)
|
49
|
4
|
0.0001
|
1.70E-02
|
KAT7,HSP90AA1,KAT2B,JUN
|
|
Regulation of telomerase (N)
|
68
|
4
|
0.0002
|
1.44E-02
|
E2F1,HSP90AA1,SP1,JUN
|
